English Polski
Vol 15, No 4 (2020)
Review paper
Published online: 2020-11-25

open access

Page views 1588
Article views/downloads 881
Get Citation

Connect on Social Media

Connect on Social Media

Myocarditis in children and adolescents: a literature review

Agnieszka Tomik1, Anna Chanas1, Bożena Werner1
Folia Cardiologica 2020;15(4):293-302.

Abstract

Myocarditis is defined by the World Health Organization as an inflammatory disease involving cardiomyocytes, interstitial tissue, vessels and occasionally the pericardium. In this article, literature from the past 5 years regarding epidemiology, diagnostic tests, treatment and prognosis in myocarditis in young children and adolescents was analyzed. For this purpose the Pubmed database was screened using the key words “myocarditis” and “children”, yielding 117 articles. This list of was narrowed down to those in which the study group consisted of at least 5 people and included information about: symptoms and signs, abnormalities in additional tests, etiology, treatment, length of hospitalization and mortality. Finally, the review included 17 studies, describing 1891 children with a diagnosis of myocarditis. The analysis shows that myocarditis is a rare disease. Two peaks of the disease are observed: the first in newborns and infants, the second one in adolescents. Age less than 2 years is a predictor of severe prognosis. In reported cases the most common symptoms were: fatigue, chest pain, palpitations or irregular heart rhythm. Tachycardia, tachypnoe, hypotension and hepatomegaly dominated among findings in physical examination. The interview, the result of physical examination and additional tests (troponin levels, electrocardiogram, echocardiogram) are helpful in making a diagnosis. Cardiac magnetic resonance imaging is used to confirm the diagnosis. In the analyzed group, 65–90% of children were treated in the Intensive Care Unit. Extracorporeal membrane oxygenation was used in 168 cases, a ventricular assist device was implanted in 35 children and 38 children underwent heart transplantation. The mortality rate in myocarditis remains high (25–35% in analyzed studies). Up to 25% of children may develop chronic heart failure. Due to the unpredictable course of this disease, patients in the acute period of the disease should be hospitalized, and after being discharge from the hospital undergo further cardiological check-up.

Article available in PDF format

View PDF Download PDF file

References

  1. Caforio ALP, Pankuweit S, Arbustini E, et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34(33): 2636–48, 2648a.
  2. Friedrich MG, Sechtem U, Schulz-Menger J, et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53(17): 1475–1487.
  3. Lurz P, Luecke C, Eitel I, et al. Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. J Am Coll Cardiol. 2016; 67(15): 1800–1811.
  4. Bejiqi R, Retkoceri R, Maloku A, et al. The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature. Open Access Maced J Med Sci. 2019; 7(1): 162–173.
  5. Mahrholdt H, Greulich S. Prognosis in myocarditis. J Am Coll Cardiol. 2017; 70(16): 1988–1990.
  6. Butts RJ, Boyle GJ, Deshpande SR, et al. Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort. Pediatr Cardiol. 2017; 38(6): 1175–1182.
  7. Messroghli DR, Pickardt T, Fischer M, et al. MYKKE Consortium. Toward evidence-based diagnosis of myocarditis in children and adolescents: Rationale, design, and first baseline data of MYKKE, a multicenter registry and study platform. Am Heart J. 2017; 187: 133–144.
  8. Lv J, Han Bo, Wang C, et al. The Clinical Features of Children With Acute Fulminant Myocarditis and the Diagnostic and Follow-Up Value of Cardiovascular Magnetic Resonance. Front Pediatr. 2019; 7: 388.
  9. Chang YJ, Hsiao HJ, Hsia SH, et al. Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis. PLoS One. 2019; 14(3): e0214087.
  10. Arola A, Pikkarainen E, Sipilä JOt, et al. Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland. J Am Heart Assoc. 2017; 6(11).
  11. Martinez-Villar M, Gran F, Sabaté-Rotés A, et al. Acute Myocarditis with Infarct-like Presentation in a Pediatric Population: Role of Cardiovascular Magnetic Resonance. Pediatr Cardiol. 2018; 39(1): 51–56.
  12. Rodriguez-Gonzalez M, Sanchez-Codez MI, Lubian-Gutierrez M, et al. Clinical presentation and early predictors for poor outcomes in pediatric myocarditis: A retrospective study. World J Clin Cases. 2019; 7(5): 548–561.
  13. Howard A, Hasan A, Brownlee J, et al. Pediatric Myocarditis Protocol: An Algorithm for Early Identification and Management with Retrospective Analysis for Validation. Pediatr Cardiol. 2020; 41(2): 316–326.
  14. Matsuura H, Ichida F, Saji T, et al. Clinical Features of Acute and Fulminant Myocarditis in Children - 2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery. Circ J. 2016; 80(11): 2362–2368.
  15. Wu HP, Lin MJ, Yang WC, et al. Predictors of Extracorporeal Membrane Oxygenation Support for Children with Acute Myocarditis. Biomed Res Int. 2017; 2017: 2510695.
  16. Butto A, Rossano JW, Nandi D, et al. Elevated Troponin in the First 72 h of Hospitalization for Pediatric Viral Myocarditis is Associated with ECMO: An Analysis of the PHIS+ Database. Pediatr Cardiol. 2018; 39(6): 1139–1143.
  17. Vigneswaran TV, Brown JR, Breuer J, et al. Parvovirus B19 myocarditis in children: an observational study. Arch Dis Child. 2016; 101(2): 177–180.
  18. Haider N, Shaikh AS, Wazir R, et al. Clinicodemographic features and outcome of acute myocarditis in children admitted at tertiary care hospital. Int J Cardiol. 2016; 221: 42–45.
  19. Casadonte JR, Mazwi ML, Gambetta KE, et al. Risk Factors for Cardiac Arrest or Mechanical Circulatory Support in Children with Fulminant Myocarditis. Pediatr Cardiol. 2017; 38(1): 128–134.
  20. Aykac K, Ozsurekci Y, Kahyaoglu P, et al. Myocarditis associated with influenza infection in five children. J Infect Public Health. 2018; 11(5): 698–701.
  21. Abrar S, Ansari MJ, Mittal M, et al. Predictors of Mortality in Paediatric Myocarditis. J Clin Diagn Res. 2016; 10(6): SC12–SC16.
  22. Lin MS, Tseng YH, Chen MY, et al. In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy. BMC Cardiovasc Disord. 2019; 19(1): 10.
  23. Brighenti M, Donti A, Giulia Gagliardi M, et al. Italian Society of Pediatric Cardiology. Endomyocardial biopsy safety and clinical yield in pediatric myocarditis: An Italian perspective. Catheter Cardiovasc Interv. 2016; 87(4): 762–767.
  24. Wei S, Fu J, Chen L, et al. Performance of Cardiac Magnetic Resonance Imaging for Diagnosis of Myocarditis Compared with Endomyocardial Biopsy: A Meta-Analysis. Med Sci Monit. 2017; 23: 3687–3696.
  25. Simpson KE, Storch GA, Lee CK, et al. High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis. Pediatr Cardiol. 2016; 37(2): 399–404.
  26. Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020; 5(7): 831–840.
  27. Huang X, Sun Y, Su G, et al. Intravenous Immunoglobulin Therapy for Acute Myocarditis in Children and Adults. Int Heart J. 2019; 60(2): 359–365.
  28. Maisch B, Alter P. Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins. Herz. 2018; 43(5): 423–430.
  29. Li Y, Yu Y, Chen S, et al. Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis. Front Pediatr. 2019; 7: 342.
  30. He B, Li X, Li D. Immunosuppressive Treatment for Myocarditis in the Pediatric Population: A Meta-Analysis. Front Pediatr. 2019; 7: 430.
  31. Masarone D, Valente F, Rubino M, et al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. Pediatr Neonatol. 2017; 58(4): 303–312.